The Magnificent Seven are still the most consequential story of the stock market, even if they’ve taken a backseat to geopolitics this year.

We take a look at eight blue chip stocks in the stock portfolio of US President Donald Trump, plus how they contribute to his ...

BioNTech and Bristol Myers Squibb have agreed to jointly develop and commercialize BioNTech's BNT327 cancer-drug candidate in a deal potentially worth more than $11 billion to the German drugmaker.

Deputy Treasury Secretary Michael Faulkender said that the Trump administration is making "good progress” on trade ...

Apple (AAPL) has faced significant challenges this year amid escalating trade tensions, driven by U.S. President Donald Trump ...

Now, with large tariffs implemented on imports from China, Apple has begun to move some of its manufacturing to India in ...

U.S. President Donald Trump's trade war has caused Apple's stock to drop by 20% this year due to Apple’s dependence on ...

Donald Trump's wide-ranging taxes on imports were reinstated this week after being deemed illegal by a trade court. Their ultimate fate is yet to be decided.

Stocks soared in May, boosted by easing trade tensions, solid corporate earnings and signs of economic resilience. Trade and ...

Warren Buffett manages the vast majority of Berkshire Hathaway 's stock portfolio, and the company made interesting capital ...

President Donald Trump’s swipes at Apple aren’t just bruising the company’s bottom line — they may also be taking a bite out of your 401(k).

Jim Cramer in a recent program on CNBC said that he had to recommend that his investing club members trim their positions in ...